Preclinical GPS
We design and implement preclinical and CMC programs for virtual biotech to mid-sized pharmaceutical companies.
We manage the preclinical science and execution so that clients can focus on running their companies.
Preclinical GPS provides the highest quality scientific and project management expertise to develop your novel drugs from concept to successful clinical products. For our clients, virtual biotech to mid-sized pharmaceutical companies, we create drug development strategies (what to do and when – and what not to do) followed by implementation of those plans. Robust project management ensures on-time/on-budget delivery of your programs.
Preclinical GPS works with new and existing biotech clients, venture companies and investors to provide expert guidance and support for drug discovery and preclinical development programs. We provide individual experts to support your team, or we can build an entire team of consultants to support your program. We completed over 40 IND programs and 30 Phase 2 programs. Preclinical GPS manages 2 to 4 INDs and Phase 2 programs each year, and supports multiple other programs in early stages of drug development.
Scientific Services
Preclinical GPS partners with clients to develop and implement preclinical drug discovery/development plans from concept to market. We support pharmacology, toxicology, pharmacokinetics and ADME studies, and CMC and formulations. We represent you and your program during interactions with regulatory agencies.
Learn More ▶Project Management
Great science makes great drugs. Great project management makes great companies. Project management is one of the most important functions within any biotech or pharmaceutical company. Great project management delivers effective progress towards goals, coordinates complicated tasks, and manages your most precious resource – time.
Learn More ▶Who We Are
Peter Korytko has over 20 years of pharmaceutical/biotech industry experience (Pfizer, Amgen, and Preclinical GPS) with preclinical development of small molecules, monoclonal antibodies, proteins, and oligonucleotides preceded by a PhD (Cornell University) and MBA (DePaul University).
Learn More ▶